MIV Therapeutics, Inc. (OTCBB: MIVT) (Frankfurt: MIV), a directive developer of next-generation coatings and modern drug-delivery systems for cardiovascular stents and another implantable scrutiny devices, announces that the prototypal patients hit been registered in the entrance effort of its VESTAsync™ polymer-free drug-eluting stent.

Tags: Led, vascular